Gabelli Funds’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Gabelli Funds’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-36,187	Closed	-$405K	–	1153
2017 Q3	$405K	Sell	36,187 -9,342	-21%	-$103K	﹤0.01%	1021
2017 Q2	$501K	Buy	+45,529	New	+$455K	﹤0.01%	1004

Gabelli Funds's SCLN Position: Q4 2017 in Review

Gabelli Funds sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 36,187 shares — an estimated $405K sold.

Gabelli Funds first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $501K in Q2 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Gabelli Funds reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Gabelli Funds sold 36,187 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $405K.
Gabelli Funds first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
Gabelli Funds's Sciclone Pharmaceuticals Inc position peaked at $501K in Q2 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Gabelli Funds's 13F filing for Q4 2017, filed 2 Feb 2018.